438 related articles for article (PubMed ID: 8566947)
21. Genetics of Wilms' tumor.
Coppes MJ; Egeler RM
Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
[TBL] [Abstract][Full Text] [Related]
22. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.
Koufos A; Grundy P; Morgan K; Aleck KA; Hadro T; Lampkin BC; Kalbakji A; Cavenee WK
Am J Hum Genet; 1989 May; 44(5):711-9. PubMed ID: 2539717
[TBL] [Abstract][Full Text] [Related]
23. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
[TBL] [Abstract][Full Text] [Related]
25. The T-ALL specific t(11;14)(p13;q11) translocation breakpoint cluster region is located near to the Wilms' tumour predisposition locus.
Boehm T; Lavenir I; Forster A; Wadey RB; Cowell JK; Harbott J; Lampert F; Waters J; Sherrington P; Couillin P
Oncogene; 1988 Dec; 3(6):691-5. PubMed ID: 2577871
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions.
Karnik P; Chen P; Paris M; Yeger H; Williams BR
Oncogene; 1998 Jul; 17(2):237-40. PubMed ID: 9674708
[TBL] [Abstract][Full Text] [Related]
27. The M1 subunit of ribonucleotide reductase refines mapping of genetic rearrangements at chromosome 11p15.
Byrne JA; Little MH; Smith PJ
Cancer Genet Cytogenet; 1992 Apr; 59(2):206-9. PubMed ID: 1316226
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
[TBL] [Abstract][Full Text] [Related]
29. Beck-Wiedemann syndrome and Wilms' tumour.
Ward A
Mol Hum Reprod; 1997 Feb; 3(2):157-68. PubMed ID: 9239720
[TBL] [Abstract][Full Text] [Related]
30. A new highly polymorphic DNA restriction site marker in the 5' region of the human tyrosine hydroxylase gene (TH) detecting loss of heterozygosity in human embryonal rhabdomyosarcoma.
Besnard-Guérin C; Cavenee WK; Newsham I
Hum Genet; 1994 Mar; 93(3):349-50. PubMed ID: 7510263
[TBL] [Abstract][Full Text] [Related]
31. Molecular biology of Wilms' tumor.
Koo HP; Hensle TW
Urol Clin North Am; 1993 May; 20(2):323-31. PubMed ID: 8388135
[TBL] [Abstract][Full Text] [Related]
32. Two anonymous DNA segments distinguish the Wilms' tumor and aniridia loci.
Davis LM; Stallard R; Thomas GH; Couillin P; Junien C; Nowak NJ; Shows TB
Science; 1988 Aug; 241(4867):840-2. PubMed ID: 2841760
[TBL] [Abstract][Full Text] [Related]
33. Telomere fusion as a mechanism for the progressive loss of the short arm of chromosome 11 in an anaplastic Wilms' tumor.
Sawyer JR; Goosen LS; Stine KC; Thomas JR
Cancer; 1994 Jul; 74(2):767-73. PubMed ID: 8033058
[TBL] [Abstract][Full Text] [Related]
34. A third Wilms' tumor locus on chromosome 16q.
Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
[TBL] [Abstract][Full Text] [Related]
35. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases.
Safford SD; Goyeau D; Freemerman AJ; Bentley R; Everett ML; Grundy PE; Skinner MA
Ann Surg Oncol; 2003 Mar; 10(2):136-43. PubMed ID: 12620908
[TBL] [Abstract][Full Text] [Related]
36. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
Byrne JA; Simms LA; Little MH; Algar EM; Smith PJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):104-11. PubMed ID: 7504513
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity for chromosome region 11p15 in Wilms' tumours is not related to HRAS gene transforming mutations.
Baird P; Wadey R; Cowell J
Oncogene; 1991 Jul; 6(7):1147-9. PubMed ID: 1861864
[TBL] [Abstract][Full Text] [Related]
38. Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene.
Rose EA; Glaser T; Jones C; Smith CL; Lewis WH; Call KM; Minden M; Champagne E; Bonetta L; Yeger H
Cell; 1990 Feb; 60(3):495-508. PubMed ID: 2154334
[TBL] [Abstract][Full Text] [Related]
39. Unbalanced translocation of chromosome 3p in Wilms' tumor.
Walton JM; Lee CL; Mikhail E; Welch JP; Gillis DA
J Pediatr Surg; 1992 Oct; 27(10):1311-4. PubMed ID: 1328583
[TBL] [Abstract][Full Text] [Related]
40. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
Haber DA; Buckler AJ
New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
